OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The blood–brain barrier as an endocrine tissue
William A. Banks
Nature Reviews Endocrinology (2019) Vol. 15, Iss. 8, pp. 444-455
Closed Access | Times Cited: 134
William A. Banks
Nature Reviews Endocrinology (2019) Vol. 15, Iss. 8, pp. 444-455
Closed Access | Times Cited: 134
Showing 26-50 of 134 citing articles:
Blood-testis barrier: a review on regulators in maintaining cell junction integrity between Sertoli cells
Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan
Cell and Tissue Research (2024) Vol. 396, Iss. 2, pp. 157-175
Closed Access | Times Cited: 15
Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan
Cell and Tissue Research (2024) Vol. 396, Iss. 2, pp. 157-175
Closed Access | Times Cited: 15
Blood-brain barrier disruption: a culprit of cognitive decline?
Ji Che, Yinying Sun, Yixu Deng, et al.
Fluids and Barriers of the CNS (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Ji Che, Yinying Sun, Yixu Deng, et al.
Fluids and Barriers of the CNS (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Blood–brain borders: a proposal to address limitations of historical blood–brain barrier terminology
Jérôme Badaut, Jean‐François Ghersi‐Egea, Robert G. Thorne, et al.
Fluids and Barriers of the CNS (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Jérôme Badaut, Jean‐François Ghersi‐Egea, Robert G. Thorne, et al.
Fluids and Barriers of the CNS (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Understanding glucose metabolism and insulin action at the blood–brain barrier: Implications for brain health and neurodegenerative diseases
Yiyi Zhu, Alexei Verkhratsky, Hui Chen, et al.
Acta Physiologica (2025) Vol. 241, Iss. 2
Open Access | Times Cited: 1
Yiyi Zhu, Alexei Verkhratsky, Hui Chen, et al.
Acta Physiologica (2025) Vol. 241, Iss. 2
Open Access | Times Cited: 1
Association between hospital-treated infectious diseases and risk of neurodegenerative disease among patients with prediabetes and diabetes: A prospective cohort study in UK Biobank
Jing Wang, Yifang Huang, Qiuli Zhu, et al.
Brain Behavior and Immunity (2025) Vol. 126, pp. 30-37
Closed Access | Times Cited: 1
Jing Wang, Yifang Huang, Qiuli Zhu, et al.
Brain Behavior and Immunity (2025) Vol. 126, pp. 30-37
Closed Access | Times Cited: 1
Understanding Microbial Mediation of the Brain-Gut Axis
J. Horn, Desiree R. Delgadillo, Emeran A. Mayer
Gastroenterology Clinics of North America (2025)
Closed Access | Times Cited: 1
J. Horn, Desiree R. Delgadillo, Emeran A. Mayer
Gastroenterology Clinics of North America (2025)
Closed Access | Times Cited: 1
Type 2 Diabetes Mellitus Increases the Risk of Late-Onset Alzheimer’s Disease: Ultrastructural Remodeling of the Neurovascular Unit and Diabetic Gliopathy
Melvin R. Hayden
Brain Sciences (2019) Vol. 9, Iss. 10, pp. 262-262
Open Access | Times Cited: 75
Melvin R. Hayden
Brain Sciences (2019) Vol. 9, Iss. 10, pp. 262-262
Open Access | Times Cited: 75
Drug-induced-acute liver failure: A critical appraisal of the thioacetamide model for the study of hepatic encephalopathy
Ali Sepehrinezhad, Ali Shahbazi, Sajad Sahab Negah, et al.
Toxicology Reports (2021) Vol. 8, pp. 962-970
Open Access | Times Cited: 45
Ali Sepehrinezhad, Ali Shahbazi, Sajad Sahab Negah, et al.
Toxicology Reports (2021) Vol. 8, pp. 962-970
Open Access | Times Cited: 45
The Vascular-Immune Hypothesis of Alzheimer’s Disease
Rashi I. Mehta, Rupal I. Mehta
Biomedicines (2023) Vol. 11, Iss. 2, pp. 408-408
Open Access | Times Cited: 21
Rashi I. Mehta, Rupal I. Mehta
Biomedicines (2023) Vol. 11, Iss. 2, pp. 408-408
Open Access | Times Cited: 21
Effects of gut microbiota on neurodegenerative diseases
Saima Khatoon, Nida Kalam, Summya Rashid, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 21
Saima Khatoon, Nida Kalam, Summya Rashid, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 21
Purinergic signaling: A gatekeeper of blood-brain barrier permeation
Yuemei Wang, Yuanbing Zhu, Jun‐Meng Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
Yuemei Wang, Yuanbing Zhu, Jun‐Meng Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier
Karan Wadhwa, PAYAL CHAUHAN, Shobhit Kumar, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 5, pp. 877-897
Open Access | Times Cited: 6
Karan Wadhwa, PAYAL CHAUHAN, Shobhit Kumar, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 5, pp. 877-897
Open Access | Times Cited: 6
Potential applications of microfluidics based blood brain barrier (BBB)-on-chips for in vitro drug development
Xiaobo Wang, Ya Hou, Xiaopeng Ai, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 132, pp. 110822-110822
Open Access | Times Cited: 47
Xiaobo Wang, Ya Hou, Xiaopeng Ai, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 132, pp. 110822-110822
Open Access | Times Cited: 47
Basic physiology of the blood-brain barrier in health and disease: a brief overview
Mehmet Kaya, Bülent Ahıshalı
Tissue Barriers (2020) Vol. 9, Iss. 1, pp. 1840913-1840913
Open Access | Times Cited: 45
Mehmet Kaya, Bülent Ahıshalı
Tissue Barriers (2020) Vol. 9, Iss. 1, pp. 1840913-1840913
Open Access | Times Cited: 45
Cell-penetrating peptides in oncologic pharmacotherapy: A review
Nuno Vale, Diana Duarte, Sara Silva, et al.
Pharmacological Research (2020) Vol. 162, pp. 105231-105231
Closed Access | Times Cited: 44
Nuno Vale, Diana Duarte, Sara Silva, et al.
Pharmacological Research (2020) Vol. 162, pp. 105231-105231
Closed Access | Times Cited: 44
The Blood-Brain Barrier Interface in Diabetes Mellitus: Dysfunctions, Mechanisms and Approaches to Treatment
William A. Banks
Current Pharmaceutical Design (2020) Vol. 26, Iss. 13, pp. 1438-1447
Closed Access | Times Cited: 43
William A. Banks
Current Pharmaceutical Design (2020) Vol. 26, Iss. 13, pp. 1438-1447
Closed Access | Times Cited: 43
Recent advances in understanding the mechanisms of PM2.5-mediated neurodegenerative diseases
Xiaozheng Zhu, Xintong Ji, Yikai Shou, et al.
Toxicology Letters (2020) Vol. 329, pp. 31-37
Closed Access | Times Cited: 43
Xiaozheng Zhu, Xintong Ji, Yikai Shou, et al.
Toxicology Letters (2020) Vol. 329, pp. 31-37
Closed Access | Times Cited: 43
Emerging Nano-Carrier Strategies for Brain Tumor Drug Delivery and Considerations for Clinical Translation
David J. Lundy, Helen Nguyễn, Patrick C.H. Hsieh
Pharmaceutics (2021) Vol. 13, Iss. 8, pp. 1193-1193
Open Access | Times Cited: 34
David J. Lundy, Helen Nguyễn, Patrick C.H. Hsieh
Pharmaceutics (2021) Vol. 13, Iss. 8, pp. 1193-1193
Open Access | Times Cited: 34
Research Progress on Nanoplatforms and Nanotherapeutic Strategies in Treating Glioma
Li Qiao, Huishu Yang, Xinxin Shao, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 7, pp. 1927-1951
Closed Access | Times Cited: 22
Li Qiao, Huishu Yang, Xinxin Shao, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 7, pp. 1927-1951
Closed Access | Times Cited: 22
Blood-brain Barrier and Neurovascular Unit Dysfunction in Parkinson's Disease: From Clinical Insights to Pathogenic Mechanisms and Novel Therapeutic Approaches
Sarah Lei Qi Khor, Khuen Yen Ng, Rhun Yian Koh, et al.
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 3, pp. 315-330
Closed Access | Times Cited: 15
Sarah Lei Qi Khor, Khuen Yen Ng, Rhun Yian Koh, et al.
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 3, pp. 315-330
Closed Access | Times Cited: 15
Alzheimer's disease pathology: pathways between chronic vascular risk factors and blood-brain barrier dysfunction in a cohort of patients with different types of dementia
Jinghuan Gan, Yang Xia, Guili Zhang, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 13
Jinghuan Gan, Yang Xia, Guili Zhang, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 13
Metabolic control of puberty: 60 years in the footsteps of Kennedy and Mitra’s seminal work
Greg M. Anderson, Jennifer W. Hill, Ursula B. Kaiser, et al.
Nature Reviews Endocrinology (2023) Vol. 20, Iss. 2, pp. 111-123
Open Access | Times Cited: 13
Greg M. Anderson, Jennifer W. Hill, Ursula B. Kaiser, et al.
Nature Reviews Endocrinology (2023) Vol. 20, Iss. 2, pp. 111-123
Open Access | Times Cited: 13
Nanotechnology Driven Lipid and Metalloid Based Formulations Targeting Blood–Brain Barrier (3B) for Brain Tumor
Amulya Jindal, Mainuddin Mainuddin, Anoop Kumar, et al.
Indian Journal of Microbiology (2024)
Closed Access | Times Cited: 5
Amulya Jindal, Mainuddin Mainuddin, Anoop Kumar, et al.
Indian Journal of Microbiology (2024)
Closed Access | Times Cited: 5
Tanycytic transcytosis inhibition disrupts energy balance, glucose homeostasis and cognitive function in male mice
Manon Duquenne, Eleonora Deligia, Cintia Folgueira, et al.
Molecular Metabolism (2024) Vol. 87, pp. 101996-101996
Open Access | Times Cited: 5
Manon Duquenne, Eleonora Deligia, Cintia Folgueira, et al.
Molecular Metabolism (2024) Vol. 87, pp. 101996-101996
Open Access | Times Cited: 5
The interactions between energy homeostasis and neurovascular plasticity
Bandy Chen, Elisa de Launoit, David Meseguer, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 12, pp. 749-759
Closed Access | Times Cited: 5
Bandy Chen, Elisa de Launoit, David Meseguer, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 12, pp. 749-759
Closed Access | Times Cited: 5
